The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 10087 malaria professionals are enjoying the free benefits of MalariaWorld today

Senegal

Prevalence of molecular markers of Plasmodium falciparum drug resistance in Dakar, Senegal

June 20, 2012 - 08:59 -- Kabogo Ndegwa
Author(s): 
Wurtz N, Fall B, Pascual A, Diawara S, Sow K, Baret E, Diatta B, Fall KB, Mbaye PS, Fall F, Diémé Y, Rogier C, Bercion R, Briolant S, Wade B, Pradines B
Reference: 
Malaria Journal 2012, 11:197 (13 June 2012)

MalariaWorldSince 2004, the prevalence of chloroquine resistance had decreased.

Country: 
City: 
Medical Treatment: 

Open Access | IgG responses to the gSG6-P1 salivary peptide for evaluating human exposure to Anopheles bites in urban areas of Dakar region, Senegal

March 22, 2012 - 07:06 -- Kabogo Ndegwa
Author(s): 
Drame PM, Machault V, Diallo A, Cornelie S, Poinsignon A, Lalou R, Sembene M, Dos Santos S, Rogier C, Pages F, Le Hesran J, Remoue F
Reference: 
Malaria Journal 2012, 11:72 (16 March 2012)

MalariaWorldSpecific human IgG responses to gSG6-P1 peptide biomarker represent, at the population and individual levels, a credible new alternative tool to assess accurately the heterogeneity of exposure level to Anopheles bites and malaria risk in low urban transmission areas.

Country: 
Medical Condition: 

Open Access | Estimating the Burden of Malaria in Senegal: Bayesian Zero-Inflated Binomial Geostatistical Modeling of the MIS 2008 Data

March 13, 2012 - 07:01 -- Kabogo Ndegwa
Author(s): 
Federica Giardina, Laura Gosoniu, Lassana Konate, Mame Birame Diouf, Robert Perry, Oumar Gaye, Ousmane Faye, Penelope Vounatsou
Reference: 
PLoS ONE 7(3): e32625

MalariaWorldThe Research Center for Human Development in Dakar (CRDH) with the technical assistance of ICF Macro and the National Malaria Control Programme (NMCP) conducted in 2008/2009 the Senegal Malaria Indicator Survey (SMIS), the first nationally representative household survey collecting parasitological data and malaria-related indicators.

Country: 
Medical Condition: 
Medical Treatment: 

Open Access | Low and seasonal malaria transmission in the middle Senegal River basin: identification and characteristics of Anopheles vectors.

January 24, 2012 - 11:30 -- Patrick Sampao
Author(s): 
Ndiath MO, Sarr J, Gaayeb L, Mazenot C, Sougoufara S, Konate L, Remoue F, Hermann E, Trape J, Riveau G, Sokhna C
Reference: 
Parasites & Vectors 2012, 5:21 (23 January 2012)

MalariaWorldWe conducted a study to assess malaria vector diversity, dynamics and malaria transmission in the area.

Country: 
Region: 

Open Access | Impact of combining intermittent preventive treatment with home management of malaria in children less than 10 years in a rural area of Senegal: a cluster randomized trial

December 15, 2011 - 15:48 -- Kabogo Ndegwa
Author(s): 
Tine RC, Faye B, Ndour CT, Ndiaye JL, Ndiaye M, Bassene C, Magnussen P, Bygbjerg IC, Sylla K, Ndour JD, Gaye O
Reference: 
Malaria Journal 2011, 10:358 (13 December 2011)

http://www.pnas.org/content/108/50/20113.abstractCombining IPTc and HMM can provide significant additional benefit in preventing clinical episodes of malaria as well as anaemia among children in Senegal.

Country: 
Medical Condition: 

Open Access | Assessing healthcare providers' knowledge and practices relating to insecticide-treated nets and the prevention of malaria in Ghana, Laos, Senegal and Tanzania

December 15, 2011 - 15:14 -- Patrick Sampao
Author(s): 
Hoffman SJ, Guindon G, Lavis JN, Ndossi GD, Osei EJ, Sidibe M, Boupha B
Reference: 
Malaria Journal 2011, 10:363 (13 December 2011)

MalariaWorldThis study points to several strategies that may help bridge the gap between what is known from research evidence and the knowledge and practices of healthcare providers.

Medical Condition: 

Open Access | Ex vivo susceptibility of Plasmodium falciparum isolates from Dakar, Senegal, to seven standard anti-malarial drugs

October 25, 2011 - 08:43 -- Kabogo Ndegwa
Author(s): 
Fall B, Diawara S, Sow K, Baret E, Diatta B, Fall KB, Mbaye PS, Fall F, Dieme Y, Rogier C, Wade B, Bercion R, Pradines B
Reference: 
Malaria Journal 2011, 10:310 (20 October 2011)

MalariaWorldThe introduction of ACT in 2002 has not induced a decrease in P. falciparum susceptibility to the drugs DHA, MDAQ and LMF, which are common ACT components. However, the prevalence of P. falciparum isolates with reduced susceptibility has increased for both MQ and DOX.

Country: 
City: 
Medical Condition: 
Medical Treatment: 

Open Access | Management of uncomplicated malaria in children under 13 years of age at a District Hospital in Senegal: from official guidelines to usual practices

October 4, 2011 - 06:49 -- Kabogo Ndegwa
Author(s): 
Sarrassat S, Lalou R, Cisse M, Le Hesran J
Reference: 
Malaria Journal 2011, 10:285 (29 September 2011)

MalariaWorldThe transition from chloroquine to AQ+SP was well followed. Nonetheless, blood smear use was very low and many over-prescriptions were reported.

Country: 
Medical Condition: 
Medical Treatment: 

Open Access | Methods to collect Anopheles mosquitoes and evaluate malaria transmission: a comparative study in two villages in Senegal

September 21, 2011 - 14:03 -- Patrick Sampao
Author(s): 
Mamadou O Ndiath, Catherine Mazenot, Ablaye Gaye, Lasanna Konate, Charles Bouganali, Ousmane Faye, Cheikh Sokhna and Jean-Francois Trape
Reference: 
Malaria Journal 2011, 10:270

Collections were performed in two villages: Dielmo (Soudan savanna) and Bandafassi (Soudan Guinean savanna), two or three nights per month for a 4-5 months period during the maximal transmission season in 2001-2002.

Country: 
Medical Condition: 

Open Access | Repeated treatment of recurrent uncomplicated Plasmodium falciparum malaria in Senegal with fixed-dose artesunate plus amodiaquine versus fixed-dose artemether plus lumefantrine: a randomized, open-label trial

August 16, 2011 - 13:04 -- Kabogo Ndegwa
Author(s): 
Ndiaye JA, Faye B, Gueye A, Tine R, Ndiaye D, Tchania C, Ndiaye I, Barry A, Cisse B, Lameyre V, Gaye O
Reference: 
Malaria Journal 2011, 10:237 (12 August 2011)

Study results confirmed the satisfactory efficacy and safety profile of ASAQ and AL. Moreover, in patients who were treated at least twice, repeated administration of ASAQ or AL did not identify any major safety issues.

Country: 
Medical Condition: 

Pages

Subscribe to RSS - Senegal